|
Name |
Xylarioxide E
|
Molecular Formula | C34H56O11 | |
IUPAC Name* |
8,9-dihydroxy-15-[3-hydroxy-5,6-dimethyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,16-dimethyl-6-oxatetracyclo[9.7.0.02,8.012,16]octadec-10-en-5-one
|
|
SMILES |
CC(C)C(C)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(C)C1CCC2C3=CC(O)C4(O)COC(=O)CCC4(C)C3CCC21C
|
|
InChI |
InChI=1S/C34H56O11/c1-16(2)17(3)30(45-31-29(41)28(40)27(39)23(14-35)44-31)26(38)18(4)20-7-8-21-19-13-24(36)34(42)15-43-25(37)10-12-33(34,6)22(19)9-11-32(20,21)5/h13,16-18,20-24,26-31,35-36,38-42H,7-12,14-15H2,1-6H3/t17-,18+,20-,21+,22+,23?,24+,26-,27?,28?,29?,30+,31?,32-,33-,34+/m1/s1
|
|
InChIKey |
MKRVNLKFOISTFF-YOJMPLBKSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 640.81 | ALogp: | 1.3 |
HBD: | 7 | HBA: | 11 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 186.4 | Aromatic Rings: | 5 |
Heavy Atoms: | 45 | QED Weighted: | 0.151 |
Caco-2 Permeability: | -5.21 | MDCK Permeability: | 0.00011403 |
Pgp-inhibitor: | 0.011 | Pgp-substrate: | 0.669 |
Human Intestinal Absorption (HIA): | 0.925 | 20% Bioavailability (F20%): | 0.042 |
30% Bioavailability (F30%): | 0.81 |
Blood-Brain-Barrier Penetration (BBB): | 0.068 | Plasma Protein Binding (PPB): | 91.65% |
Volume Distribution (VD): | 0.767 | Fu: | 4.84% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.099 |
CYP2C19-inhibitor: | 0.002 | CYP2C19-substrate: | 0.472 |
CYP2C9-inhibitor: | 0.001 | CYP2C9-substrate: | 0.077 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.1 |
CYP3A4-inhibitor: | 0.073 | CYP3A4-substrate: | 0.158 |
Clearance (CL): | 1.584 | Half-life (T1/2): | 0.041 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.131 |
Drug-inuced Liver Injury (DILI): | 0.048 | AMES Toxicity: | 0.095 |
Rat Oral Acute Toxicity: | 0.545 | Maximum Recommended Daily Dose: | 0.033 |
Skin Sensitization: | 0.004 | Carcinogencity: | 0.036 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.003 |
Respiratory Toxicity: | 0.878 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004803 | 0.500 | D04RYU | 0.370 | ||||
ENC004804 | 0.454 | D0AR3J | 0.347 | ||||
ENC005438 | 0.454 | D0S0NK | 0.344 | ||||
ENC004757 | 0.454 | D0M2QH | 0.331 | ||||
ENC001984 | 0.454 | D09HTS | 0.319 | ||||
ENC004550 | 0.448 | D07TGN | 0.310 | ||||
ENC005016 | 0.444 | D0SL2V | 0.305 | ||||
ENC001889 | 0.410 | D0P6IK | 0.300 | ||||
ENC001769 | 0.410 | D07ORO | 0.278 | ||||
ENC003121 | 0.378 | D0M3QP | 0.277 |